Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jul;3(7):884-99.
doi: 10.3390/toxins3070884. Epub 2011 Jul 15.

G(i/o) protein-dependent and -independent actions of Pertussis Toxin (PTX)

Affiliations
Review

G(i/o) protein-dependent and -independent actions of Pertussis Toxin (PTX)

Supachoke Mangmool et al. Toxins (Basel). 2011 Jul.

Abstract

Pertussis toxin (PTX) is a typical A-B toxin. The A-protomer (S1 subunit) exhibits ADP-ribosyltransferase activity. The B-oligomer consists of four subunits (S2 to S5) and binds extracellular molecules that allow the toxin to enter the cells. The A-protomer ADP-ribosylates the α subunits of heterotrimeric G(i/o) proteins, resulting in the receptors being uncoupled from the G(i/o) proteins. The B-oligomer binds proteins expressed on the cell surface, such as Toll-like receptor 4, and activates an intracellular signal transduction cascade. Thus, PTX modifies cellular responses by at least two different signaling pathways; ADP-ribosylation of the Gα(i/o) proteins by the A-protomer (G(i/o) protein-dependent action) and the interaction of the B-oligomer with cell surface proteins (G(i/o) protein-independent action).

Keywords: A-protomer; ADP-ribosylation; B-oligomer; G protein-coupled receptor; Gi/o-dependent; Gi/o-independent; Toll-like receptor 4; heterotrimeric G protein; pertussis toxin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pertussis toxin (PTX) structural organization. PTX contains five different subunits that are arranged in a typical A-B structure. The A-protomer contains an enzymatically active S1 subunit that is on the top of B-oligomer. The B-oligomer is composed of two dimers, S2-S4 and S3-S4 dimers, which are held together by the S5 subunit.
Figure 2
Figure 2
Schematic diagram of the ADP-ribosylation of α subunit of heterotrimeric Gi/o protein by pertussis toxin (PTX). PTX catalyzes the cleavage of the C-N bond between a carbon atom of ribose and a nitrogen atom of nicotinamide, and transfers the ADP-ribosyl moiety to an acceptor molecule.
Figure 3
Figure 3
Uncoupling of Gαi/o proteins from their cognate G protein-coupled receptor (GPCR). Activation of GPCRs leads to dissociation of heterotrimeric G protein complex into Gαi/o and βγ subunit. The exchange of GTP from GDP results in activation of the inhibitory G protein (Gαi/o), thereby inhibiting adenylyl cyclase (AC) activity. When the A-protomer of PTX penetrates into the host cells, the Gαi/o is ADP-ribosylated at cysteine residue resulting in inactivation of Gαi/o. The inhibitory effect of Gαi/o on AC activity results in the elevation of intracellular cAMP levels, leading to activation of the cAMP-mediated signaling pathway. This enhanced pathway by PTX is recognized as the Gi/o protein-dependent pathway.
Figure 4
Figure 4
Gi/o protein-dependent and -independent effects of PTX. Following the binding of PTX to host cells, the A-protomer penetrates through the cell membrane. A-protomer is dissociated from B-oligomer and released into the cytoplasm. A-protomer then catalyzes the ADP-ribosylation of Gαi/o that leads to uncoupling of Gαi/o from its cognate inhibitory GPCRs. The inhibitory effect of Gαi/o on AC activity is then halted, resulting in accumulation of cAMP. This action of PTX results in disruption of cellular function through cAMP-mediated signaling pathway (Gi/o protein-dependent effects). In a separate pathway, the B-oligomer binds to and interacts with several targeted proteins on the plasma membrane, leading to the induction of the biological responses that are independent of ADP-ribosylation of Gαi/o protein (Gi/o protein-independent effects).

References

    1. Holbourn K.P., Shone C.C., Acharya K.R. A family of killer toxins. Exploring the mechanism of ADP-ribosylating toxins. FEBS J. 2006;273:4579–4593. - PubMed
    1. Locht C., Antoine R. A proposed mechanism of ADP-ribosylation catalyzed by the pertussis toxin S1 subunit. Biochimie. 1995;77:333–340. - PubMed
    1. Pittman M. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Rev. Infect. Dis. 1979;1:401–412. doi: 10.1093/clinids/1.3.401. - DOI - PubMed
    1. Burns D.L. Subunit structure and enzymic activity of pertussis toxin. Microbiol. Sci. 1988;5:285–287. - PubMed
    1. Katada T., Ui M. ADP ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity. J. Biol. Chem. 1982;257:7210–7216. - PubMed

MeSH terms

LinkOut - more resources